Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The impact of high frequency rapid viral antigen screening on COVID-19 spread and outcomes: a validation and modeling study

Beatrice Nash, Anthony Badea, Ankita Reddy, Miguel Bosch, Nol Salcedo, Adam R. Gomez, Alice Versiani, Gislaine Celestino Dutra Silva, Thayza Maria Izabel Lopes dos Santos, Bruno H. G. A. Milhim, Marilia M. Moraes, Guilherme Rodrigues Fernandes Campos, Flávia Quieroz, Andreia Francesli Negri Reis, Mauricio L. Nogueira, Elena N. Naumova, Irene Bosch, View ORCID ProfileBobby Brooke Herrera
doi: https://doi.org/10.1101/2020.09.01.20184713
Beatrice Nash
1E25Bio, Inc., Cambridge, MA, USA
2Department of Computer Science, Harvard University School of Engineering and Applied Sciences, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony Badea
1E25Bio, Inc., Cambridge, MA, USA
3Department of Physics, Harvard University, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ankita Reddy
1E25Bio, Inc., Cambridge, MA, USA
4Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miguel Bosch
1E25Bio, Inc., Cambridge, MA, USA
5InfoGeosciences LLC, Houston, TX, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nol Salcedo
1E25Bio, Inc., Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam R. Gomez
1E25Bio, Inc., Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alice Versiani
6Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gislaine Celestino Dutra Silva
6Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thayza Maria Izabel Lopes dos Santos
6Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno H. G. A. Milhim
6Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marilia M. Moraes
6Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guilherme Rodrigues Fernandes Campos
6Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Flávia Quieroz
6Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreia Francesli Negri Reis
6Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mauricio L. Nogueira
6Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena N. Naumova
7Division of the Nutrition Epidemiology and Data Science, Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irene Bosch
1E25Bio, Inc., Cambridge, MA, USA
8Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bobby Brooke Herrera
1E25Bio, Inc., Cambridge, MA, USA
9Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bobby Brooke Herrera
  • For correspondence: bbherrera@e25bio.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

High frequency screening of populations has been proposed as a strategy in facilitating control of the COVID-19 pandemic. Here we use computational modeling, coupled with clinical data from a rapid antigen test, to predict the impact of frequent rapid testing on COVID-19 spread and outcomes. Using patient nasopharyngeal swab specimens, we demonstrate that the sensitivity and specificity of the rapid antigen test compared to quantitative real-time polymerase chain reaction (qRT-PCR) are 84.7% and 85.7%, respectively; moreover, sensitivity correlates directly with viral load. Based on COVID-19 data from three regions in the United States and São José do Rio Preto, Brazil, we show that high frequency, strategic population-wide rapid testing, even at varied accuracy levels, diminishes COVID-19 infections, hospitalizations, and deaths at a fraction of the cost of nucleic acid detection via qRT-PCR. We propose large-scale antigen-based surveillance as a viable strategy to control SARS-CoV-2 spread and to enable societal re-opening.

Competing Interest Statement

BN, AB, AR, MB, NS, AG, IB, and BBH are employed by or affiliated with E25Bio Inc. (www.e25bio.com), a company that develops diagnostics for epidemic viruses.

Funding Statement

We thank Professor Lee Gehrke for critical reading of the manuscript. The study is funded, in part, by a Bill and Melinda Gates Foundation Award (INV-017872) to E25Bio, Inc. EN is funded by Tufts University DISC Seed Grant. MLN is supported by a FAPESP grant (#2020/04836-0) and is a CNPq Research Fellow. AFV is supported by a FAPESP Fellow grant (#18/17647-0). GRFC is supported by a FAPESP Fellow grant (#20/07419-0). BHGAM is supported by a FAPESP Scholarship (#19/06572-2). The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The primary study under which the samples and data were collected received ethical clearance from the Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP), protocol number 31588920.0.0000.5415. All excess samples and corresponding data were banked and de-identified prior to the analyses.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The authors confirm that the data supporting the findings of this study are available within the article and/or its supplementary materials; any other data will be made available upon request. Our code can be found on github: https://github.com/badeaa3/COVID19_Rapid_Testing.

https://github.com/badeaa3/COVID19_Rapid_Testing

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 04, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The impact of high frequency rapid viral antigen screening on COVID-19 spread and outcomes: a validation and modeling study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The impact of high frequency rapid viral antigen screening on COVID-19 spread and outcomes: a validation and modeling study
Beatrice Nash, Anthony Badea, Ankita Reddy, Miguel Bosch, Nol Salcedo, Adam R. Gomez, Alice Versiani, Gislaine Celestino Dutra Silva, Thayza Maria Izabel Lopes dos Santos, Bruno H. G. A. Milhim, Marilia M. Moraes, Guilherme Rodrigues Fernandes Campos, Flávia Quieroz, Andreia Francesli Negri Reis, Mauricio L. Nogueira, Elena N. Naumova, Irene Bosch, Bobby Brooke Herrera
medRxiv 2020.09.01.20184713; doi: https://doi.org/10.1101/2020.09.01.20184713
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
The impact of high frequency rapid viral antigen screening on COVID-19 spread and outcomes: a validation and modeling study
Beatrice Nash, Anthony Badea, Ankita Reddy, Miguel Bosch, Nol Salcedo, Adam R. Gomez, Alice Versiani, Gislaine Celestino Dutra Silva, Thayza Maria Izabel Lopes dos Santos, Bruno H. G. A. Milhim, Marilia M. Moraes, Guilherme Rodrigues Fernandes Campos, Flávia Quieroz, Andreia Francesli Negri Reis, Mauricio L. Nogueira, Elena N. Naumova, Irene Bosch, Bobby Brooke Herrera
medRxiv 2020.09.01.20184713; doi: https://doi.org/10.1101/2020.09.01.20184713

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (496)
  • Anesthesia (106)
  • Cardiovascular Medicine (1109)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (505)
  • Epidemiology (9795)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2327)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1567)
  • Health Policy (737)
  • Health Systems and Quality Improvement (608)
  • Hematology (238)
  • HIV/AIDS (508)
  • Infectious Diseases (except HIV/AIDS) (11665)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (240)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2152)
  • Nursing (134)
  • Nutrition (340)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (519)
  • Oncology (1184)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (221)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (313)
  • Pediatrics (699)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (268)
  • Psychiatry and Clinical Psychology (2195)
  • Public and Global Health (4680)
  • Radiology and Imaging (785)
  • Rehabilitation Medicine and Physical Therapy (458)
  • Respiratory Medicine (625)
  • Rheumatology (275)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (211)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)